Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 11 Nasopharyngeal Carcinoma 5 Nasopharyngeal Neoplasms 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Recurrence 2 Unresectable Non-small Cell Lung Cancer 1 Squamous Non-small Cell Lung Cancer 1 Squamous Non-Small Cell Lung Cancer SqNSCLC 1 Optic Nerve Glioma 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neuroblastoma 1 Neoplasms 1 Melanoma 1 Lymphoma, T-Cell 1 Lung Neoplasms 1 Locally Advanced Squamous Non-small Cell Lung Cancer 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Advanced Pancreatic Cancer 1 Adenoma, Islet Cell 1

Interventions

Carboplatin 3 Radiotherapy 2 Doxorubicin 2 tipifarnib 1 etoposide phosphate 1 becatecarin 1 Vincristine 1 Temozolomide 1 Tamoxifen 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 RMP 7 1 Perfusion Magnetic Resonance Imaging 1 Oxaliplatin 1 Megestrol Acetate 1 Lenalidomide 1 Irinotecan 1 Immunologic Techniques 1 Etoposide 1 Endostatins 1 Dynamic Contrast Enhanced Magnetic Resonance Imaging 1 Cyproheptadine 1 Cisplatin 1 Cilengitide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Optic Nerve Glioma × Endostatins × Clear all

NCT05278715 2024-10-15

Modified CV Regimen in Optic Pathway Glioma

Beijing Sanbo Brain Hospital

Phase 2 Recruiting

Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡